ClinicalTrials.Veeva

Menu

Study of Esophageal Squamous Dysplasia Prevalence at Tenwek Hospital (STEP)

T

Tenwek Hospital

Status

Completed

Conditions

Esophageal Dysplasia

Study type

Observational

Funder types

Other

Identifiers

NCT01981876
P172/06/2010

Details and patient eligibility

About

Esophageal squamous cell cancer (ESCC) is common in the developing world, and is the leading cancer diagnosis at Tenwek Hospital in southwestern Kenya. The investigators long-term goal is to understand the pathogenesis and risk factors for ESCC in Kenya, and to establish effective screening and prevention programs. The investigators hypothesize that asymptomatic esophageal squamous dysplasia (ESD) is common in their region, and the current protocol is designed to determine the prevalence of ESD in residents of southwestern Kenya.

Full description

The prevalence of esophageal squamous dysplasia will be determined after evaluating pathology reports from unstained lesions and normal biopsies after staining with Lugol's iodine.

Enrollment

305 patients

Sex

All

Ages

20 to 79 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 20 years
  • No dysphagia (subjects will be asked "do you have trouble swallowing food or water? Do they get stuck inside after you swallow?" in their primary language

Exclusion criteria

  • Cardiac, respiratory, or metabolic disease that would increase the risk of endoscopy: history of myocardial infarction, arrhythmias, chronic obstructive pulmonary disease, diabetes, allergy to lidocaine.
  • Unable or unwilling to provide informed consent.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems